[The anti-arrhythmia properties of bonnecor metabolites]

Farmakol Toksikol. 1990 May-Jun;53(3):48-50.
[Article in Russian]

Abstract

The experiments on the model of aconitine-induced arrhythmia in anesthetized rats and awake dogs with cardiac rhythm disorders caused by the coronary artery occlusion showed that all four metabolites of bonnecor possessed the antiarrhythmic activity. Metabolite 4 proved to be the most active on both models of cardiac rhythm disorders.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Aconitine
  • Animals
  • Anti-Arrhythmia Agents / metabolism
  • Anti-Arrhythmia Agents / therapeutic use*
  • Arrhythmias, Cardiac / drug therapy
  • Arrhythmias, Cardiac / etiology
  • Dibenzazepines / metabolism
  • Dibenzazepines / therapeutic use*
  • Dogs
  • Drug Evaluation, Preclinical
  • Rats
  • Time Factors

Substances

  • Anti-Arrhythmia Agents
  • Dibenzazepines
  • tiracizine
  • Aconitine